Atherosclerosis remains a major cause of mortality in the US. Even a more striking statistic is subjects with Type 2 diabetes are 4 to 5 times more likely to suffer a heart attack than someone without diabetes. Although much has been learned about the vascular cell components that contribute to atherosclerosis, it has only recently become accepted that immune cells play an important role in atherosclerosis. The mechanisms for how immune cells modulate atherosclerosis are unclear, and this is an emerging field of research that could lead to promising new therapies. We are a long-standing team of investigators who have been studying atherosclerosis and type 2 diabetes for the last 15 years. The focus of this PPG renewal is to study the immunobiology of atherosclerosis. Project 1 will study T regulatory lymphocyte function in atherosclerosis. Project 2 will investigate the synergy between endotoxemia and oxidized cholesteryl esters in TLR-mediated vascular inflammation. Project 3 will test the role of the transcriptional repressor ld3 in modulating B lymphocyte function in atherosclerosis. A Human Phenotyping and Immune Cell Core will provide human blood samples for immune cell phenotyping for each project. The purpose of this Administrative Core (Core A) is to coordinate the PPG by providing scientific administration, grant and fiscal management, and coordination of scientific advisory meetings.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
La Jolla Institute
La Jolla
United States
Zip Code
Tsimikas, Sotirios; Duff, Gordon W; Berger, Peter B et al. (2014) Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J Am Coll Cardiol 63:1724-34
Willeit, Peter; Kiechl, Stefan; Kronenberg, Florian et al. (2014) Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol 64:851-60
Ai, Ding; Jiang, Hongfeng; Westerterp, Marit et al. (2014) Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis. Circ Res 114:1576-84
Manichaikul, Ani; Rich, Stephen S; Perry, Heather et al. (2014) A functionally significant polymorphism in ID3 is associated with human coronary pathology. PLoS One 9:e90222
Lazic, Milos; Inzaugarat, Maria Eugenia; Povero, Davide et al. (2014) Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis. PLoS One 9:e107658
Cheng, Hsin-Yuan; Wu, Runpei; Hedrick, Catherine C (2014) Gammadelta (??) T lymphocytes do not impact the development of early atherosclerosis. Atherosclerosis 234:265-9
Morris-Rosenfeld, Samuel; Lipinski, Michael J; McNamara, Coleen A (2014) Understanding the role of B cells in atherosclerosis: potential clinical implications. Expert Rev Clin Immunol 10:77-89
Fang, Longhou; Liu, Chao; Miller, Yury I (2014) Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis. Transl Res 163:99-108
Ge, Shuwang; Hertel, Barbara; Koltsova, Ekaterina K et al. (2013) Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. Circ Res 113:965-74
Cheng, Hsin-Yuan; Wu, Runpei; Gebre, Abraham K et al. (2013) Increased cholesterol content in gammadelta (ýýýý) T lymphocytes differentially regulates their activation. PLoS One 8:e63746

Showing the most recent 10 out of 141 publications